Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMY Bristol-Myers Squibb	$46.99 0.0%	$52.31	$39.35 ▼ $63.33	$95.63B	0.39	13.18 million shs	11.03 million shs
DE Deere & Company	$515.56 +0.2%	$471.37	$340.20 ▼ $533.78	$139.93B	1.08	1.41 million shs	948,493 shs
TECK Teck Resources	$35.47 -0.5%	$35.65	$28.32 ▼ $54.13	$17.48B	0.79	3.14 million shs	1.98 million shs

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMY Bristol-Myers Squibb	-1.82%	+6.60%	-4.05%	-15.82%	+11.06%
DE Deere & Company	-2.05%	+3.69%	+16.56%	+3.78%	+33.15%
TECK Teck Resources	-0.79%	-3.82%	+8.91%	-17.77%	-33.26%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BMY Bristol-Myers Squibb	4.6996 of 5 stars	3.2	3.0	4.2	4.0	4.0	3.3	0.0
DE Deere & Company	4.4612 of 5 stars	2.2	5.0	2.5	1.5	3.8	1.7	2.5
TECK Teck Resources	4.8857 of 5 stars	4.4	5.0	1.7	0.0	2.9	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BMY Bristol-Myers Squibb	2.32	Hold	$58.00	23.43% Upside
DE Deere & Company	2.37	Hold	$516.75	0.23% Upside
TECK Teck Resources	2.81	Moderate Buy	$64.11	80.74% Upside

Current Analyst Ratings Breakdown

Latest DE, TECK, and BMY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/21/2025	DE Deere & Company	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform ➝ Market Perform	$425.00 ➝ $460.00
5/19/2025	DE Deere & Company	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$450.00 ➝ $550.00
5/19/2025	DE Deere & Company	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$455.00 ➝ $493.00
5/16/2025	DE Deere & Company	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$546.00 ➝ $619.00
5/16/2025	DE Deere & Company	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$513.00 ➝ $555.00
5/16/2025	DE Deere & Company	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$530.00 ➝ $560.00
5/16/2025	DE Deere & Company	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$542.00 ➝ $542.00
5/16/2025	DE Deere & Company	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$495.00 ➝ $556.00
5/16/2025	DE Deere & Company	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$475.00 ➝ $530.00
5/16/2025	DE Deere & Company	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$501.00 ➝ $514.00
4/25/2025	BMY Bristol-Myers Squibb	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold

(Data available from 5/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BMY Bristol-Myers Squibb	$47.64B	2.01	$4.96 per share	9.48	$8.08 per share	5.82
DE Deere & Company	$46.93B	2.98	$35.29 per share	14.61	$82.56 per share	6.24
TECK Teck Resources	$9.74B	1.80	$5.41 per share	6.56	$40.32 per share	0.88

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BMY Bristol-Myers Squibb	-$8.95B	$2.67	N/A	7.72	2.07	-18.53%	13.93%	2.46%	7/25/2025 (Estimated)
DE Deere & Company	$7.10B	$20.67	22.85	23.40	2.14	12.94%	27.31%	5.87%	N/A
TECK Teck Resources	$1.78B	$0.58	64.50	19.49	N/A	2.96%	4.59%	2.50%	7/23/2025 (Estimated)

Latest DE, TECK, and BMY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/15/2025	Q2 2025	DE Deere & Company	$5.72	$6.64	+$0.92	$6.64	$10.80 billion	$11.17 billion
4/24/2025	Q1 2025	BMY Bristol-Myers Squibb	$1.50	$1.80	+$0.30	$1.21	$10.77 billion	$11.20 billion
4/24/2025	Q1 2025	TECK Teck Resources	$0.24	$0.42	+$0.18	$0.51	$2.19 billion	$1.60 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BMY Bristol-Myers Squibb	$2.48	5.28%	+6.38%	92.88%	17 Years
DE Deere & Company	$6.48	1.26%	+15.63%	31.35%	4 Years
TECK Teck Resources	$0.34	0.96%	+35.72%	58.62%	N/A

Latest DE, TECK, and BMY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/25/2025	TECK Teck Resources	quarterly	$0.0901	1%	6/16/2025	6/16/2025	6/30/2025
2/26/2025	DE Deere & Company	quarterly	$1.62	1.35%	3/31/2025	3/31/2025	5/8/2025
3/3/2025	BMY Bristol-Myers Squibb	quarterly	$0.62	4.14%	4/4/2025	4/4/2025	5/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BMY Bristol-Myers Squibb	2.90	1.25	1.15
DE Deere & Company	1.94	2.22	1.98
TECK Teck Resources	0.16	2.92	2.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BMY Bristol-Myers Squibb	76.41%
DE Deere & Company	68.58%
TECK Teck Resources	78.06%

Insider Ownership

Company	Insider Ownership
BMY Bristol-Myers Squibb	0.07%
DE Deere & Company	0.29%
TECK Teck Resources	0.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BMY Bristol-Myers Squibb	34,300	2.04 billion	2.03 billion	Optionable
DE Deere & Company	82,200	271.41 million	271.56 million	Optionable
TECK Teck Resources	12,100	492.72 million	498.05 million	Optionable

DE, TECK, and BMY Headlines

Recent News About These Companies

Ulysses Management LLC Lowers Position in Teck Resources Limited (NYSE:TECK)

May 22 at 7:06 AM | marketbeat.com

Focus Partners Wealth Has $685,000 Stock Position in Teck Resources Limited (NYSE:TECK)

May 22 at 3:54 AM | marketbeat.com

90 Tons, No Driver, and -40°C—China’s Driverless Trucks are Redefining the Norm

May 21 at 3:32 PM | msn.com

Teck Resources Limited (NYSE:TECK) Shares Sold by Toronto Dominion Bank

May 21 at 5:58 AM | marketbeat.com

Nuveen Asset Management LLC Boosts Stock Position in Teck Resources Limited (NYSE:TECK)

May 21 at 4:56 AM | marketbeat.com

Teck Resources Limited (NYSE:TECK) Shares Acquired by Cetera Investment Advisers

May 21 at 3:36 AM | marketbeat.com

Temasek Holdings Private Ltd Has $44.51 Million Holdings in Teck Resources Limited (NYSE:TECK)

May 20 at 7:49 AM | marketbeat.com

TFG Asset Management GP Ltd Decreases Stock Holdings in Teck Resources Limited (NYSE:TECK)

May 20 at 6:16 AM | marketbeat.com

Thornburg Investment Management Inc. Decreases Stake in Teck Resources Limited (NYSE:TECK)

May 20 at 6:15 AM | marketbeat.com

Sagefield Capital LP Raises Stake in Teck Resources Limited (NYSE:TECK)

May 19 at 7:30 AM | marketbeat.com

Point72 Asia Singapore Pte. Ltd. Acquires Shares of 10,916 Teck Resources Limited (NYSE:TECK)

May 18, 2025 | marketbeat.com

Point72 Europe London LLP Raises Holdings in Teck Resources Limited (NYSE:TECK)

May 18, 2025 | marketbeat.com

Teck Resources Limited (NYSE:TECK) Stock Position Raised by Gotham Asset Management LLC

May 17, 2025 | marketbeat.com

Ameriprise Financial Inc. Trims Position in Teck Resources Limited (NYSE:TECK)

May 17, 2025 | marketbeat.com

Northern Trust Corp Boosts Holdings in Teck Resources Limited (NYSE:TECK)

May 17, 2025 | marketbeat.com

3 TSX Stocks Estimated To Be Trading 27.6% To 48% Below Intrinsic Value

May 16, 2025 | finance.yahoo.com

Spill of treated water reported at Red Dog Mine in Northwest Alaska

May 15, 2025 | yahoo.com

Merewether Investment Management LP Boosts Stake in Teck Resources Limited (NYSE:TECK)

May 15, 2025 | marketbeat.com

Moore Capital Management LP Cuts Stock Holdings in Teck Resources Limited (NYSE:TECK)

May 15, 2025 | marketbeat.com

Hudson Bay Capital Management LP Has $3.85 Million Stock Holdings in Teck Resources Limited (NYSE:TECK)

May 15, 2025 | marketbeat.com

Teck Resources Limited (NYSE:TECK) Shares Acquired by Deutsche Bank AG

May 15, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?
By Jeffrey Neal Johnson | April 25, 2025
View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?
Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
By Nathan Reiff | April 30, 2025
View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
NVIDIA Stock Surges on Bullish News: How High Could It Climb?
By Thomas Hughes | May 13, 2025
View NVIDIA Stock Surges on Bullish News: How High Could It Climb?
Broadcom Set to Surge as AI Diffusion Rule Ends
By Leo Miller | May 15, 2025
View Broadcom Set to Surge as AI Diffusion Rule Ends
2 Smart Investments to Follow Warren Buffett’s Lead
By Ryan Hasson | April 23, 2025
View 2 Smart Investments to Follow Warren Buffett’s Lead

DE, TECK, and BMY Company Descriptions

Bristol-Myers Squibb NYSE:BMY

$46.99 -0.01 (-0.02%)

Closing price 03:59 PM Eastern

Extended Trading

$47.18 +0.18 (+0.39%)

As of 07:59 PM Eastern

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Deere & Company NYSE:DE

$515.56 +0.90 (+0.17%)

Closing price 03:59 PM Eastern

Extended Trading

$515.00 -0.56 (-0.11%)

As of 07:54 PM Eastern

Deere & Co. engages in the manufacture and distribution of equipment used in agriculture, construction, forestry, and turf care. It operates through the following segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment focuses on the distribution and manufacture of a full line of agriculture and turf equipment and related service parts. The Construction and Forestry segment offers machines and service parts used in construction, earthmoving, road building, material handling and timber harvesting. The Financial Services segment finances sales and leases by John Deere dealers of new and used agriculture and turf equipment and construction and forestry equipment. The company was founded by John Deere in 1837 and is headquartered in Moline, IL.

Teck Resources NYSE:TECK

$35.47 -0.17 (-0.47%)

Closing price 03:59 PM Eastern

Extended Trading

$35.48 +0.00 (+0.01%)

As of 05:02 PM Eastern

Teck Resources Limited engages in exploring for, acquiring, developing, and producing natural resources in Asia, Europe, and North America. The company operates through Steelmaking Coal, Copper, Zinc, and Energy segments. Its principal products include copper, zinc, steelmaking coal, and blended bitumen. The company also produces lead, silver, and molybdenum; and various specialty and other metals, chemicals, and fertilizers. In addition, it explores for gold. The company was formerly known as Teck Cominco Limited and changed its name to Teck Resources Limited in April 2009. The company was founded in 1913 and is headquartered in Vancouver, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time